nach oben

memo - Magazine of European Medical Oncology

Erschienen in:

26.05.2020 | original report

Rectal cancer among younger Egyptian patients—clinico-pathological features and oncologic outcomes: A single institution experience

verfasst von: Amir M. Zaid, Engy M. Aboelnaga, MD, Amal Halim, Mohamed Abdelkhalek, Saleh S. Elbalka, Mohamed Zuhdy, Ahmed M. Fareed, Eman M. Ibrahim, Hosam Halim, Islam H. Metwally

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Summary

Our younger rectal carcinoma cases had poorer pathologic criteria but the therapy was the crucial factor affecting their survival. Full course of radiotherapy was crucial for better OS of the younger group (P = 0.014), while chemotherapy was crucial for better DFS/PFS in both the young and old age groups (P = 0.00).

Vorheriger Artikel The future of combination therapies in advanced melanoma

Nächster Artikel Chemoradiotherapy alone or chemoradiotherapy followed by surgery in rectal cancer

De Felice F, Musio D, Izzo L, Tombolini V. Neoadjuvant chemoradiotherapy for locally advanced rectal cancer: the debate continues. World J Gastrointest Oncol. 2014;6:438–40.CrossRef

den Dulk M, Krijnen P, Marijnen CA, Rutten HJ, van de Poll-Franse VL, Putter H, et al. Improved overall survival for patients with rectal cancer since 1990: the effects of TME surgery and pre-operative radiotherapy. Eur J Cancer. 2008;44(12):1710–6.CrossRef

Sauer R, Becker H, Hohenberger W, Rodel C, Wittekin C, Fietkau R, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731–40.CrossRef

Atkin WS, Cuzick J. Screening for colorectal cancer. Lancet. 1993;341:1667.CrossRef

Bailey CE, Hu CY, You YN, Bednarski BK, Rodriguez-Bigas MA, Skibber JM, et al. Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975–2010. JAMA Surg. 2015;150(1):17–22.CrossRef

O’Connell JB, Maggard MA, Liu JH, Etzioni DA, Livingston EH, Ko CY. Rates of colon and rectal cancers are increasing in young adults. Am Surg. 2003;69:866–72.PubMed

Meyer JE, Narang T, Schnoll-Sussman FH, Pochapin MB, Christos PL, Sherr DL. Increasing incidence of rectal cancer in patients aged younger than 40 years:an analysis of the surveillance, epidemiology, and end results database. Cancer. 2010;116(18):4354–9.CrossRef

Davis DM, Marcet JE, Frattini JC, Prather AD, Mateka JJ, Nfonsam VN. Is it time to lower the recommended screening age for colorectal cancer? J Am Coll Surg. 2011;213(3):352–61.CrossRef

Endreseth BH, Romundstad P, Myrvold HE, McDonald JC. Rectal cancer in the young patient. Dis Colon Rectum. 2006;49(7):993–1001.CrossRef

10.

Marble K, Banerjee S, Greenwald L. Colorectal carcinoma in young patients. J Surg Oncol. 1992;51:179e182.CrossRef

11.

Ganapathi S, Kumar D, Katsoulas N, Melville D, Hodgson S, Finlayson C. Colorectal cancer in the young: trends, characteristics and outcome. Int J Colorectal Dis. 2011;26(7):927–34.CrossRef

12.

You YN, Dozois EJ, Boardman LA, Aakre J, Huebner M, Larson DW. Young-onset rectal cancer: presentation, pattern of care and long-term oncologic outcomes compared to a matched older-onset cohort. Ann Surg Oncol. 2011;18(9):2469–76.CrossRef

13.

O’Connell JB, Maggard MA, Livingston EH, Yo CK. Colorectal cancer in the young. Am J Surg. 2004;187:343–8.CrossRef

14.

Quah HM, Joseph R, Schrag D, Shia J, Guillem JG, Paty PB, et al. Young age influences treatment but not outcome of colon cancer. Ann Surg Oncol. 2007;14:2759–65.CrossRef

15.

Metwally IH, Shetiwy M, Elalfy AF, Abouzid A, Saleh SS, Hamdy M. Epidemiology and survival of colon cancer among Egyptians: a retrospective study. J Coloproctol. 2019;39(4):339–45.CrossRef

16.

Georgiou A, Khakoo S, Edwards P, Minchom A, Kouvelakis K, Kalaitzaki E, et al. Outcomes of patients with early onset colorectal cancer treated in a UK specialist cancer center. Cancers. 2019;11(10):E1558.CrossRef

17.

Benedix F, Kuester D, Meyer F, Lippert H. Influence of mucinous and signet-ring cell differentiation on epidemiological, histological, molecular biological features, and outcome in patients with colorectal carcinoma. Zentralbl Chir. 2013;138(4):427–33.PubMed

18.

Kolarich A, George TJ Jr, Hughes SJ, Delitto D, Allegra CJ, Hall WA, et al. Rectal cancer patients younger than 50 years lack a survival benefit from NCCN guideline-directed treatment for Stage II and III disease. Cancer. 2018;124(17):3510–9.CrossRef

19.

Keane MG, Johnson GJ. Early diagnosis improves survival in colorectal cancer. Practitioner. 1753;256:15–8.

20.

Orbell J, West NJ. Improving Detection of Colorectal Cancer. Practitioner. 2010;254(1733):17–21.PubMed

21.

Junginger T, Hermanek P, Oberholzer K, Schmidberger H. Rectal carcinoma: Is too much neoadjuvant therapy performed? proposals for a more selective MRI based indication. Zentralbl Chir. 2006;131(4):275–84.CrossRef

22.

Haroon N, Khan S, Rehman Alvi R. Rectal carcinoma under 40 years of age: seven-year post-treatment follow-up at a tertiary care hospital in Pakistan. J Pak Med Assoc. 2013;63(12):1460–3.PubMed

23.

Tawadros PS, Paquette IM, Hanly AM, Mellgren AF, Rothenberger DA, Madoff RD. Adenocarcinoma of the rectum in patients under age 40 is increasing: Impact of signet-ring cell histology. Dis Colon Rectum. 2015;58(5):474–8.CrossRef

24.

Korphaisarn K, Morris V, Davis JS, Michael J, Overman MJ, Fogelman DR, et al. Signet ring cell colorectal cancer: genomic insights into a rare subpopulation of colorectal adenocarcinoma. Br J Cancer. 2019;121:505–10.CrossRef

25.

Mekenkamp L, Krieken J, Marijnen C, van de Velde C, Nagtegaal I. Pathology review committee and the co-operative clinical investigators. Lymph node retrieval in rectal cancer is dependent on many factors—the role of the tumor, the patient, the surgeon, the radiotherapist, and the pathologist. Am J Surg Pathol. 2009;33(10):1547–53.CrossRef

26.

Bustamante-Lopez L, Nahas CS, Nahas SC, Ribeiro U Jr, Marques CF, Cotti G, et al. Understanding the factors associated with reduction in the number of lymph nodes in rectal cancer patients treated by neoadjuvant treatment. Int J Colorectal Dis. 2017;32(6):925–7.CrossRef

27.

Meyer J, Cohen S, Ruth K, Sigurdson E, Hall M. Young age increases risk of lymph node positivity in early-stage rectal cancer. J Natl Cancer Inst. 2016; https://doi.org/10.1093/jnci/djv284.CrossRefPubMed

28.

Barreto S, Chaubal G, Talole S, DeSouza A, Suradkar K, Gaikwad V, et al. Rectal cancer in young indians—are these cancers different compared to their older counterparts? Indian J Gastroenterol. 2014;33(2):146–50.CrossRef

29.

Carrara A, Mangiola D, Pertile R, Ricci A, Motter M, Ghezzi G, et al. Analysis of risk factors for lymph nodal involvement in early stages of rectal cancer: When can local excision be considered an appropriate treatment? Systematic review and meta-analysis of the literature. Rectal Cancer: Multimodal Treatment Approach. Int J Surg Oncol. 2012;2012:438450.PubMedPubMedCentral

30.

Inoki K, Sakamoto T, Takamaru H, Sekiguchi M, Yamada M, Nakajima T, et al. Predictive relevance of lymphovascular invasion in T1 colorectal cancer before endoscopic treatment. Endosc Int Open. 2017;5(12):E1278–E83.CrossRef

31.

Maksimović S. Survival rates of patients with mucinous adenocarcinoma of the colorectum. Med Arh. 2007;61(1):26–9.PubMed

32.

Riihimäki M, Hemminki A, Sundquist J, Hemminki K. Patterns of metastasis in colon and rectal cancer. Sci Rep. 2016;6:29765.CrossRef

33.

Pokharkar A, Bhandare M, Patil P, Mehta S, Engineer R, Avanish P, et al. Young vs. old colorectal cancer in Indian subcontinent: a tertiary care center experience. Indian J Surg Oncol. 2017;8(4):491–8.CrossRef

34.

Poles GC, Clark DE, Mayo SW, Beierle EA, Goldfarb M, Kenneth W, et al. Colorectal carcinoma in pediatric patients: a comparison with adult tumors, treatment and outcomes from the national cancer database. Pediatr Surg. 2016;51(7):1061–6.CrossRef

35.

Zhao L, Feng Bao F, Yan J, Liu H, Li T, Chen H, et al. Poor prognosis of young patients with colorectal cancer: a retrospective study. Int J Colorectal Dis. 2017;32((8):1147–56.CrossRef

36.

Orsini RG, Verhoeven RH, Lemmens VE, Steenbergen LN, de Hingh IH, Nieuwenhuijzen GA, et al. Comparable survival for young rectal cancer patients, despite unfavourable morphology and more advanced-stage disease. Eur J Cancer. 2015;51(13):1675–82.CrossRef

37.

Purim O, Gordon N, Brenner B. Cancer of the colon and rectum: potential effects of sex-age interactions on incidence and outcome. Med Sci Monit. 2013;19:203–9.CrossRef

38.

Gao J, Shao Y, Wang X, Shan Y. Clinicopathological comparison between young and old patients with rectal cancer controlled clinical trial. Zhonghua Wei Chang Wai Ke Za Zhi. 2008;11(1):54–6.PubMed

39.

Zhang R, Zhao J, Xu J, Chen Y. Long-term outcomes and prognostic factors of young patients with mucinous and signet-ring cell colorectal cancer. Arch Med Sci. 2020;16(2):359–65.CrossRef

Titel: Rectal cancer among younger Egyptian patients—clinico-pathological features and oncologic outcomes: A single institution experience
verfasst von: Amir M. Zaid
Engy M. Aboelnaga, MD
Amal Halim
Mohamed Abdelkhalek
Saleh S. Elbalka
Mohamed Zuhdy
Ahmed M. Fareed
Eman M. Ibrahim
Hosam Halim
Islam H. Metwally
Publikationsdatum: 26.05.2020
Verlag: Springer Vienna
Erschienen in: memo - Magazine of European Medical Oncology / Ausgabe 3/2020
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI: https://doi.org/10.1007/s12254-020-00622-z

Springer Medizin Österreich

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2020

Patient-reported outcomes and psycho-oncological screening in hematology: a practical example of routine electronic monitoring

Biologically effective dose and overall survival in stereotactic body radiotherapy for lung tumors

Treatment of advanced melanoma

Highlights of ASH 2019—multiple myeloma

Adjuvant and neoadjuvant treatment of melanoma

memo—publisher’s report 2019